TERBINAFINE HYDROCHLORIDE vs VORICONAZOLE

Compare TERBINAFINE HYDROCHLORIDE (Terbinafine) and VORICONAZOLE (VFEND) — clinical data, side effects, and patient experiences.

TERBINAFINE HYDROCHLORIDE

Terbinafine · Antifungal

How it works

12.1 Mechanism of Action Terbinafine is an allylamine antifungal [see ] .

Approved for

1 INDICATIONS AND USAGE Terbinafine tablets are indicated for the treatment of onychomycosis of the toenail or fingernail due to dermatophytes (tinea unguium). Prior to initiating treatment

appropriate nail specimens for laboratory testing [potassium hydroxide (KOH) preparation

fungal culture

OralTablet

VORICONAZOLE

VFEND · Antifungal

How it works

12.1 Mechanism of Action Voriconazole is an antifungal drug [see Microbiology (12.4) ].

Approved for

in patients intolerant of

or refractory to

other therapy ( 1.4 ) 1.1 Invasive Aspergillosis VFEND is indicated in adults and pediatric patients (2 years of age and older) for the treatment of invasive aspergillosis (IA). In clinical trials

kidney

IntravenousTablet

Quick Comparison

TERBINAFINE HYDROCHLORIDEVORICONAZOLE

Drug Class

Antifungal

Route

Oral

Intravenous

Half-Life

—

FDA Approved

—

Side Effect Frequency Comparison

Estimated frequency (%) based on clinical trial data

Side Effects

TERBINAFINE HYDROCHLORIDE

Drug Not Working

>10%

Rash

1-10%

Itching

1-10%

Fatigue

1-10%

Nausea

1-10%

Headache

1-10%

Diarrhea

1-10%

Shortness of Breath

0.1-1%

VORICONAZOLE

Drug Not Working

>10%

Fever

1-10%

Condition Worsened

1-10%

Diarrhea

0.1-1%

Nausea

0.1-1%

Shortness of Breath

0.1-1%

FDA Warnings

TERBINAFINE HYDROCHLORIDE

5 WARNINGS AND PRECAUTIONS • Liver failure, sometimes leading to liver transplant or death, has occurred with the use of oral terbinafine
1 Hepatotoxicity Terbinafine tablets are contraindicated for patients with chronic or active liver disease
Cases of liver failure, some leading to liver transplant or death, have occurred with the use of terbinafine tablets in individuals with and without preexisting liver disease
In the majority of liver cases reported in association with use of terbinafine tablets, the patients had serious underlying systemic conditions

VORICONAZOLE

5 WARNINGS AND PRECAUTIONS • Hepatic Toxicity : Serious hepatic reactions reported
5 ) • Photosensitivity : Avoid sunlight due to risk of photosensitivity ( 5
1 Hepatic Toxicity In clinical trials, there have been uncommon cases of serious hepatic reactions during treatment with VFEND (including clinical hepatitis, cholestasis and fulminant hepatic failure, including fatalities)
Instances of hepatic reactions were noted to occur primarily in patients with serious underlying medical conditions (predominantly hematological malignancy)

Clinical Trial Data

No head-to-head clinical studies found for TERBINAFINE HYDROCHLORIDE vs VORICONAZOLE.

TERBINAFINE HYDROCHLORIDE vs VORICONAZOLE: What You Should Know

Key Differences

Both TERBINAFINE HYDROCHLORIDE and VORICONAZOLE belong to the Antifungal class. While they share a similar mechanism of action, differences in pharmacokinetics, dosing, and side effect profiles may make one more suitable than the other for individual patients. TERBINAFINE HYDROCHLORIDE is administered via Oral, whereas VORICONAZOLE uses Intravenous. Route of administration can affect onset of action and patient adherence.

Safety Considerations

TERBINAFINE HYDROCHLORIDE carries 4 FDA warnings. VORICONAZOLE carries 4 FDA warnings. Patients should discuss all warnings and contraindications with their healthcare provider before starting or switching medications..

This comparison is for informational purposes only. Always consult a qualified healthcare professional before making medication decisions.

Related Comparisons

KETOCONAZOLE vs TERBINAFINE HYDROCHLORIDE→NYSTATIN vs TERBINAFINE HYDROCHLORIDE→METRONIDAZOLE vs TERBINAFINE HYDROCHLORIDE→CLOTRIMAZOLE TOPICAL vs TERBINAFINE HYDROCHLORIDE→AMPHOTERICIN B vs TERBINAFINE HYDROCHLORIDE→TAVABOROLE TOPICAL SOLUTION vs TERBINAFINE HYDROCHLORIDE→

Loading comparison data...

TERBINAFINE HYDROCHLORIDE vs VORICONAZOLE

Compare TERBINAFINE HYDROCHLORIDE (Terbinafine) and VORICONAZOLE (VFEND) — clinical data, side effects, and patient experiences.

TERBINAFINE HYDROCHLORIDE

Terbinafine · Antifungal

How it works

12.1 Mechanism of Action Terbinafine is an allylamine antifungal [see ] .

Approved for

1 INDICATIONS AND USAGE Terbinafine tablets are indicated for the treatment of onychomycosis of the toenail or fingernail due to dermatophytes (tinea unguium). Prior to initiating treatment

appropriate nail specimens for laboratory testing [potassium hydroxide (KOH) preparation

fungal culture

OralTablet

VORICONAZOLE

VFEND · Antifungal

How it works

12.1 Mechanism of Action Voriconazole is an antifungal drug [see Microbiology (12.4) ].

Approved for

in patients intolerant of

or refractory to

other therapy ( 1.4 ) 1.1 Invasive Aspergillosis VFEND is indicated in adults and pediatric patients (2 years of age and older) for the treatment of invasive aspergillosis (IA). In clinical trials

kidney

IntravenousTablet

Quick Comparison

TERBINAFINE HYDROCHLORIDEVORICONAZOLE

Drug Class

Antifungal

Route

Oral

Intravenous

Half-Life

—

FDA Approved

—

Side Effect Frequency Comparison

Estimated frequency (%) based on clinical trial data

Side Effects

TERBINAFINE HYDROCHLORIDE

Drug Not Working

>10%

Rash

1-10%

Itching

1-10%

Fatigue

1-10%

Nausea

1-10%

Headache

1-10%

Diarrhea

1-10%

Shortness of Breath

0.1-1%

VORICONAZOLE

Drug Not Working

>10%

Fever

1-10%

Condition Worsened

1-10%

Diarrhea

0.1-1%

Nausea

0.1-1%

Shortness of Breath

0.1-1%

FDA Warnings

TERBINAFINE HYDROCHLORIDE

5 WARNINGS AND PRECAUTIONS • Liver failure, sometimes leading to liver transplant or death, has occurred with the use of oral terbinafine
1 Hepatotoxicity Terbinafine tablets are contraindicated for patients with chronic or active liver disease
Cases of liver failure, some leading to liver transplant or death, have occurred with the use of terbinafine tablets in individuals with and without preexisting liver disease
In the majority of liver cases reported in association with use of terbinafine tablets, the patients had serious underlying systemic conditions

VORICONAZOLE

5 WARNINGS AND PRECAUTIONS • Hepatic Toxicity : Serious hepatic reactions reported
5 ) • Photosensitivity : Avoid sunlight due to risk of photosensitivity ( 5
1 Hepatic Toxicity In clinical trials, there have been uncommon cases of serious hepatic reactions during treatment with VFEND (including clinical hepatitis, cholestasis and fulminant hepatic failure, including fatalities)
Instances of hepatic reactions were noted to occur primarily in patients with serious underlying medical conditions (predominantly hematological malignancy)

Clinical Trial Data

No head-to-head clinical studies found for TERBINAFINE HYDROCHLORIDE vs VORICONAZOLE.

TERBINAFINE HYDROCHLORIDE vs VORICONAZOLE: What You Should Know

Key Differences

Safety Considerations

This comparison is for informational purposes only. Always consult a qualified healthcare professional before making medication decisions.